Lipovation

Specializing in Lipid-based Nano/micro Particle Medicines

Health Tech & Life Sciences

Acquired (Inactive) by Revium Rx on Feb 2025 - closed due to acquisition

Acquired Herzliya Founded 2021

Total raised

—

Stage

Acquired

Founded

2021

Headcount

Herzliya

Sector

Health Tech & Life Sciences

About

LipoVation’s core technology was conceptualized by Prof. Yehezkel Barenholz, a world-renowned scientist and the inventor of Doxil, the first FDA-approved liposomal chemotherapy drug, widely used in the treatment of ovarian cancer, multiple myeloma, and AIDS-related Kaposi’s sarcoma.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Name	Lipovation
Slug	lipovation
Type	Israeli Startup
Founded	2021
HQ city	Herzliya
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Acquired
Public stage	Acquired
Total raised (USD)	0
Crunchbase ID	lipovation
Israeli Companies Registrar	516352408

Name	Role	LinkedIn
David Akunis
Erez Koren

Lipovation

About

Sectors & technology

Lipovation — Full Company Profile (machine-readable)

About

Facts

Acquisitions (1)

Team (2)

News mentions (1)

About

Sectors & technology

Generate Slim Page